KTTA
Pasithea Therapeutics CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$20.32M
P/E Ratio
—
EPS
$-1.42
Beta
0.25
52W High
$2.06
52W Low
$0.28
50-Day MA
$0.72
200-Day MA
$0.81
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Pasithea Therapeutics Corp
Pasithea Therapeutics Corp. The company is headquartered in Miami Beach, Florida.
Fundamentals
| Revenue (TTM) | 486,560 |
| Gross Profit (TTM) | -2,213 |
| EBITDA | $-17.23M |
| Operating Margin | 0.00% |
| Return on Equity | -58.20% |
| Return on Assets | -31.50% |
| Revenue/Share (TTM) | $0.37 |
| Book Value | $2.20 |
| Price-to-Book | 0.37 |
| Price-to-Sales (TTM) | 42.15 |
| EV/Revenue | 277.44 |
| EV/EBITDA | 2.90 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1498.00% |
| Shares Outstanding | $33.41M |
| Float | $18.68M |
| % Insiders | 1.11% |
| % Institutions | 60.04% |
Historical Volatility
HV 10-Day
63.94%
HV 20-Day
59.15%
HV 30-Day
77.98%
HV 60-Day
66.50%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($3.00 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026